Dialysis News and Research RSS Feed - Dialysis News and Research

When your kidneys are healthy, they clean your blood. They also make hormones that keep your bones strong and your blood healthy. When your kidneys fail, you need treatment to replace the work your kidneys used to do. Unless you have a kidney transplant, you will need a treatment called dialysis.

There are two main types of dialysis: hemodialysis and peritoneal dialysis. Both types filter your blood to rid your body of harmful wastes, extra salt and water. Hemodialysis does that with a machine. Peritoneal dialysis uses the lining of your abdomen, called the peritoneal membrane, to filter your blood. Each type has both risks and benefits. They also require that you follow a special diet. Your doctor can help you decide the best type of dialysis for you.
Study: Only one-third of patients receive living donor kidney transplant pre-emptively

Study: Only one-third of patients receive living donor kidney transplant pre-emptively

A kidney transplant is a life-changing and life-saving procedure. Yet, a new study conducted by Mayo Clinic and the University of Michigan shows that only one-third of patients who ultimately receive a living donor kidney transplant receive it pre-emptively (i.e., before starting dialysis). Less than two-thirds receive a transplant either pre-emptively or within a year of starting dialysis. [More]
Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

CANTEL MEDICAL CORP., has entered into a definitive agreement with North American Science Associates, Inc. to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million. [More]
Mild reduction in food intake slows development of autosomal-dominant polycystic kidney disease

Mild reduction in food intake slows development of autosomal-dominant polycystic kidney disease

A small reduction in food intake—less than required to cause weight loss—dramatically slowed the development of a common genetic disorder called autosomal-dominant polycystic kidney disease (ADPKD) in mice, a new study in American Journal of Physiology—Renal Physiology reports. [More]
Adhering to certain diet may help postpone need for dialysis in CKD patients

Adhering to certain diet may help postpone need for dialysis in CKD patients

Adhering to a certain diet may help postpone the need for dialysis in patients with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. [More]
USRDS report shows positive and negative trends in kidney disease in the U.S.

USRDS report shows positive and negative trends in kidney disease in the U.S.

The annual data report from the United States Renal Data System reveals both positive and negative trends in kidney disease in the U.S. [More]
Better coordination could help reduce hospital readmissions, mortality rates

Better coordination could help reduce hospital readmissions, mortality rates

Better coordination between hospitals and post-acute care facilities could reduce patient readmission to hospitals and mortality rates, according to a new study of risk factors by researchers from the University of Colorado School of Medicine. [More]
Colorado state employees now have access to Paladina Health's family practice physicians

Colorado state employees now have access to Paladina Health's family practice physicians

Paladina Health, an innovative primary care approach to delivering individualized health care, announced today that State of Colorado employees and their eligible dependents who have health coverage through UnitedHealthcare now have access to Paladina Health's family practice physicians in Colorado. [More]
JINARC (tolvaptan) accepted for use in Scotland for ADPKD treatment

JINARC (tolvaptan) accepted for use in Scotland for ADPKD treatment

From today, people in Scotland with the genetic kidney disease ADPKD could benefit from JINARC® (tolvaptan) following advice issued by the Scottish Medicines Consortium (SMC) for its use in adults with chronic kidney disease (CKD) stages 1-3 at the start of treatment with evidence of rapidly progressing disease. [More]
BookWise Solutions installs unique software package at Southmead Hospital's renal department in Bristol

BookWise Solutions installs unique software package at Southmead Hospital's renal department in Bristol

UK healthcare scheduling expert BookWise Solutions Limited has expanded its services in Southmead Hospital in Bristol by installing a brand new, unique software package in Dialysis Services at the hospital’s renal department. [More]
New allocation system boosts kidney transplantation rates for black and Hispanic patients on waiting lists

New allocation system boosts kidney transplantation rates for black and Hispanic patients on waiting lists

Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon. [More]
Ardelyx announces positive results from RDX022 clinical study for treatment of hyperkalemia

Ardelyx announces positive results from RDX022 clinical study for treatment of hyperkalemia

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced positive results of an open label clinical study evaluating the pharmacodynamic (PD) activity of RDX022 in healthy adult volunteers. [More]
Argon Medical Devices completes acquisition of three vascular products from Rex Medical

Argon Medical Devices completes acquisition of three vascular products from Rex Medical

Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE Retrievable Vena Cava Filter, CLEANER Rotational Thrombectomy System, and UltraStream Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc. [More]
MUSC researchers awarded NIH grant to study use of technology for kidney transplant patients

MUSC researchers awarded NIH grant to study use of technology for kidney transplant patients

A group of MUSC researchers in the College of Medicine's Department of Surgery and the College of Nursing has been awarded a $1.11 million National Institutes of Health grant to examine a novel use of mobile health technology to reduce kidney transplant recipient premature graft loss. [More]
Infusing small dose of cytokine can prevent or reverse diabetes-related kidney failure

Infusing small dose of cytokine can prevent or reverse diabetes-related kidney failure

Diabetes is the leading cause of kidney failure, and scientists have found that infusing just a small dose of a cytokine, thought to help cause that failure, can instead prevent or reverse it. [More]
Evolocumab drug offers no added benefit over appropriate comparator therapy

Evolocumab drug offers no added benefit over appropriate comparator therapy

Evolocumab (trade name: Repatha) has been approved since July 2015 for two therapeutic indications: on the one hand, for hypercholesterolaemia or mixed dyslipidaemia, and on the other, for homozygous familial hypercholesterolaemia. [More]
Prevalence of chronic kidney disease considerably varies across Europe

Prevalence of chronic kidney disease considerably varies across Europe

The first study to carefully characterize the prevalence of chronic kidney disease (CKD) across Europe found considerable variation. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology. [More]
HealthCare Partners Medical Group receives IHA Medicare Advantage 4.5 Star Award

HealthCare Partners Medical Group receives IHA Medicare Advantage 4.5 Star Award

DaVita HealthCare Partners, a leading independent medical group in America and leading provider of kidney care services, today announced that HealthCare Partners Medical Group has received the Integrated Healthcare Association's Medicare Advantage 4.5 Star Award. [More]
Dietary cocoa flavanols may benefit cardiovascular health of patients with poor kidney function

Dietary cocoa flavanols may benefit cardiovascular health of patients with poor kidney function

Consuming a beverage containing cocoa flavanols improves blood vessel function in patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology. [More]
Australian researchers develop new technique to combat chronic bacterial infections in hospitals

Australian researchers develop new technique to combat chronic bacterial infections in hospitals

One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found. [More]
Variant signs worldwide exclusive license and development agreement with L&F Research

Variant signs worldwide exclusive license and development agreement with L&F Research

Variant Pharmaceuticals, Inc., an emerging pharmaceutical company focusing on rare diseases and other specialty conditions with limited or sub-optimal therapeutic options, announced today a worldwide exclusive license and development agreement with L&F Research LLC to advance development of Variant's lead product, VAR 200. [More]
Advertisement